Supplement industry criticizes saw palmetto study

Article

A study published in the Feb. 9 edition of the New England Journal of Medicine suggesting that the popular supplement saw palmetto is ineffective in easing problems associated with an enlarged prostate has several flaws, according to the National Nutritional Foods Association (NNFA). NNFA cited a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH).

A study published in the Feb. 9 edition of the New England Journal of Medicine suggesting that the popular supplement saw palmetto is ineffective in easing problems associated with an enlarged prostate has several flaws, according to the National Nutritional Foods Association (NNFA). NNFA cited a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH).

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

To go to the Drug Topics homepage, click here http://www.drugtopics.com.

Recent Videos
Related Content
FDA Approves Mavyret for Treatment of Acute HCV Infection

FDA Approves Mavyret for Treatment of Acute HCV Infection

Killian Meara
June 12th 2025
Article

The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.

The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies

The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies

Brian Nowosielski;Marta Wosinska, PhD;Joey Mattingly, PharmD, MBA, PhD
June 12th 2025
Podcast

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Ashley Gallagher
June 12th 2025
Article

Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.

Scripted for Her: Addressing Preconception Health Through MTM

Scripted for Her: Addressing Preconception Health Through MTM

Killian Meara;Natalie DiPietro Mager, PharmD, PhD;David Bright, PharmD, MBA
June 9th 2025
Podcast

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

Kathryn Wheeler, PharmD, BCPS
June 12th 2025
Article

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk

Bob Kronemyer
June 12th 2025
Article

Direct-to-consumer drug sales may undermine patient care and threaten independent pharmacies by reducing access to personalized, comprehensive medication management.

© 2025 MJH Life Sciences

All rights reserved.